|
1
|
Lenz O, Elliot SJ and Stetler-Stevenson
WG: Matrix metalloproteinases in renal development and disease. J
Am Soc Nephrol. 11:574–581. 2000.PubMed/NCBI
|
|
2
|
Catania JM, Chen G and Parrish AR: Role of
matrix metalloproteinases in renal pathophysiologies. Am J Physiol
Renal Physiol. 292:F905–F911. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cai G, Zhang X, Hong Q, et al: Tissue
inhibitor of metalloproteinase-1 exacerbated renal interstitial
fibrosis through enhancing inflammation. Nephrol Dial Transplant.
23:1861–1875. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hartleroad JY, Beharry KD, Hausman N,
Stavitsky Y, Asrat T and Modanlou HD: Effect of maternal
administration of selective cyclooxygenase (COX)-2 inhibitors on
renal size, growth factors, proteinases, and COX-2 secretion in the
fetal rabbit. Biol Neonate. 87:246–253. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Piedagnel R, Murphy G, Ronco PM and
Lelongt B: Matrix metalloproteinase 2 (MMP2) and MMP-9 are produced
by kidney collecting duct principal cells but are differentially
regulated by SV40 large-T, arginine vasopressin, and epidermal
growth factor. J Biol Chem. 274:1614–1620. 1999. View Article : Google Scholar
|
|
6
|
Siefert SA and Sarkar R: Matrix
metalloproteinases in vascular physiology and disease. Vascular.
20:210–216. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rémy L: Current data on
metalloproteinases, obligatory partners of tumor progression.
Pathol Biol (Paris). 45:759–765. 1997.(In French).
|
|
8
|
Visse R and Nagase H: Matrix
metalloproteinases and tissue inhibitors of metalloproteinases:
structure, function, and biochemistry. Circ Res. 92:827–839. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tomita M, Koike H, Han GD, Shimizu F and
Kawachi H: Decreased collagen-degrading activity could be a marker
of prolonged mesangial matrix expansion. Clin Exp Nephrol. 8:17–26.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Carome MA, Striker LJ, Peten EP, et al:
Human glomeruli express TIMP-1 mRNA and TIMP-2 protein and mRNA. Am
J Physiol. 264:F923–F929. 1993.PubMed/NCBI
|
|
11
|
Musiał K and Zwolińska D: Matrix
metalloproteinases (MMP-2,9) and their tissue inhibitors (TIMP-1,2)
as novel markers of stress response and atherogenesis in children
with chronic kidney disease (CKD) on conservative treatment. Cell
Stress Chaperones. 16:97–103. 2011.PubMed/NCBI
|
|
12
|
Liu Y, Rajur K, Tolbert E and Dworkin LD:
Endogenous hepatocyte growth factor ameliorates chronic renal
injury by activating matrix degradation pathways. Kidney Int.
58:2028–2024. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Rysz J, Banach M and Stolarek RA: Serum
matrix metalloproteinases MMP-2 and MMP-9 and metalloproteinase
tissue inhibitors TIMP-1 and TIMP-2 in diabetic nephropathy. J
Nephrol. 20:444–452. 2007.PubMed/NCBI
|
|
14
|
Chung AW, Yang HH, Sigrist MK, et al:
Matrix metalloproteinase-2 and -9 exacerbate arterial stiffening
and angiogenesis in diabetes and chronic kidney disease. Cardiovasc
Res. 84:494–504. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nicholas SB, Yuan J, Aminzadeh A, Norris
KC, Crum A and Vaziri ND: Salutary effects of a novel oxidative
stress modulator on adenine-induced chronic progressive
tubulointerstitial nephropathy. Am J Transl Res. 4:257–268.
2012.
|
|
16
|
Dai YQ, Jin DZ, Zhu XZ and Lei DL:
Triptolide inhibits COX-2 expression via NF-kappa B pathway in
astrocytes. Neurosci Res. 55:154–160. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Morishita Y, Ohnishi A and Watanabe M:
Establishment of acute kidney injury mouse model by 0.75% adenine
ingestion. Ren Fail. 33:1013–1018. 2011.PubMed/NCBI
|
|
18
|
Kuroda T, Yoshida Y, Kamiie J, et al:
Expression of MMP-9 in mesangial cells and its changes in anti-GBM
glomerulonephritis in WKY rats. Clin Exp Nephrol. 8:206–215. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
González-Avila G, Iturria C,
Vadillo-Ortega F, Ovalle C and Montaño M: Changes in matrix
metalloproteinases during the evolution of interstitial renal
fibrosis in a rat experimental model. Pathobiology. 66:196–204.
1998.PubMed/NCBI
|
|
20
|
Uchio-Yamada K, Manabe N, Goto Y, et al:
Decreased expression of matrix metalloproteinases and tissue
inhibitors of metalloproteinase in the kidneys of hereditary
nephrotic (ICGN) mice. J Vet Med Sci. 67:35–41. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chang HR, Yang SF, Li ML, Lin CC, Hsieh YS
and Lian JD: Relationships between circulating matrix
metalloproteinase-2 and -9 and renal function in patients with
chronic kidney disease. Clin Chim Acta. 366:243–248. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
He W, Tan RJ, Li Y, et al: Matrix
metalloproteinase-7 as a surrogate marker predicts renal
Wnt/β-catenin activity in CKD. J Am Soc Nephrol. 23:294–304.
2012.PubMed/NCBI
|
|
23
|
Duymelinck C, Dauwe SE, De Greef KE, et
al: TIMP-1 gene expression and PAI-1 antigen after unilateral
ureteral obstruction in the adult male rat. Kidney Int.
58:1186–1201. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hörstrup JH, Gehrmann M, Schneider B, et
al: Elevation of serum and urine levels of TIMP-1 and tenascin in
patients with renal disease. Nephrol Dial Transplant. 17:1005–1013.
2002.PubMed/NCBI
|
|
25
|
Suddek GM, El-Kenawi AE, Abdel-Aziz A and
El-Kashef HA: Celecoxib, a selective cyclooxygenase-2 inhibitor,
attenuates renal injury in a rat model of Cisplatin-induced
nephrotoxicity. Chemotherapy. 57:321–326. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Shibakawa A, Yudoh K, Masuko-Hongo K, Kato
T, Nishioka K and Nakamura H: The role of subchondral bone
resorption pits in osteoarthritis: MMP production by cells derived
from bone marrow. Osteoarthritis Cartilage. 13:679–687. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kim JY, Choeng HC, Ahn C and Cho SH: Early
and late changes of MMP-2 and MMP-9 in bleomycin-induced pulmonary
fibrosis. Yonsei Med J. 50:68–77. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Peng WH, Tien YC, Huang CY, et al:
Fraxinus rhynchophylla ethanol extract attenuates carbon
tetrachloride-induced liver fibrosis in rats via down-regulating
the expressions of uPA, MMP-2, MMP-9 and TIMP-1. J Ethnopharmacol.
127:606–613. 2010. View Article : Google Scholar
|
|
29
|
Qin YH, Lei FY, Hu P, et al: Effect of
all-trans retinoic acid on renal expressions of matrix
metalloproteinase-2, matrix metalloproteinase-9 and tissue
inhibitor of metalloproteinase-1 in rats with glomerulosclerosis.
Pediatr Nephrol. 24:1477–1486. 2009. View Article : Google Scholar : PubMed/NCBI
|
